Novabay Pharmaceuticals Inc
ASE:NBY 4:00:00 PM EDT
| Market Cap (Intraday) | 2.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 2.67 |
| 10-Day MA | $0.09 |
| 50-Day MA | $0.13 |
| 200-Day MA | $0.36 |
Novabay Pharmaceuticals Inc Stock, ASE:NBY
2000 Powell Street, Suite 1150, Emeryville, California 94608-1866
United States of America
Phone: +1.510.899.8800
Number of Employees: 26
Description
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.